Joseph W. Turgeon

2017

In 2017, Joseph W. Turgeon earned a total compensation of $2.4M as President and Chief Executive Officer at Spectrum Pharmaceuticals, a 77% increase compared to previous year.

Compensation breakdown

Bonus$342,000
Option Awards$456,590
Salary$600,000
Stock Awards$879,330
Other$72,465
Total$2,350,385

Turgeon received $879.3K in stock awards, accounting for 37% of the total pay in 2017.

Turgeon also received $342K in bonus, $456.6K in option awards, $600K in salary and $72.5K in other compensation.

Rankings

In 2017, Joseph W. Turgeon's compensation ranked 4,734th out of 14,666 executives tracked by ExecPay. In other words, Turgeon earned more than 67.7% of executives.

ClassificationRankingPercentile
All
4,734
out of 14,666
68th
Division
Manufacturing
1,676
out of 5,772
71st
Major group
Chemicals And Allied Products
491
out of 2,075
76th
Industry group
Drugs
377
out of 1,731
78th
Industry
Pharmaceutical Preparations
298
out of 1,333
78th
Source: SEC filing on May 7, 2018.

Turgeon's colleagues

We found three more compensation records of executives who worked with Joseph W. Turgeon at Spectrum Pharmaceuticals in 2017.

2017

Rajesh Shrotriya

Spectrum Pharmaceuticals

Chief Executive Officer

2017

Kurt Gustafson

Spectrum Pharmaceuticals

Chief Financial Officer

2017

Thomas Riga

Spectrum Pharmaceuticals

Chief Operating Officer

News

You may also like